Fulfilling Promise, Enzo Diagnostics Sues Digene for Patent Infringement | GenomeWeb

NEW YORK, March 21 - Fulfilling its promise, Enzo Diagnostics has filed a patent-infringement suit against Digene that seeks an injunction and monetary damages.
 
Additionally, Enzo Biochem, Enzo Diagnostic's parent, asked the federal district court to dismiss a declaratory judgment suit that Digene filed on March 14. Enzo claims that the suit "incorrectly named" Enzo Biochem as the adverse party, although it claims never to have owned the patent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.